Bristol Myers Squibb BMY
NYSE BMY
$62.55 +1.43 (+2.34%)
As of: Oct 22, 2026 · 10:50 AM EDT

Bristol Myers Squibb (BMY) Short-Term Debt repayments (2024)

Updated

Bristol Myers Squibb (BMY) posted Short-Term Debt repayments of $3 billion for FY2024.

Analysis

Bristol Myers Squibb (BMY) Short-Term Debt repayments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn -
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 6.45 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn -
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn -
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn -
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn -
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Bristol Myers Squibb 127.27 Bn 78.54 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 269.00 Mn
API Access

Bristol Myers Squibb Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BMY&period=max&api_key=YOUR_API_KEY